Ovum raises $1.7m for women's AI health assistant
Make us a preferred source
Make us a preferred source on Google
The news: Women's health technology company Ovum has raised $1.7 million to develop and launch what it describes as the first holistic artificial intelligence health assistant for women.
The funding round was led by Giant Leap with participation from Antler, Wollemi Capital, Nakatomi Venture Studio, Alice Anderson Fund and other investors.
The numbers: The company secured $1.7 million in funding and previously received a $20,000 grant through the LIFTwomen APAC cohort.
The context: Founded by Dr Ariella Heffernan-Mark, medical doctor and reproductive biology specialist, Ovum is developing a platform that integrates medical records, biometric data and menstrual tracking.
The platform completed a successful beta test and allows women to ask questions and track health issues while maintaining privacy. The company plans to commence clinical trials in 2025 through the George Institute for Global Health.
Ovum aims to address what it describes as a $1 trillion gender health gap problem. According to the company, one in two Australian women suffer from a chronic health condition, and around one million Australian women have endometriosis, with diagnosis taking between seven to 12 years.
What they said: "Ovum is the solution to this problem. This is about using new technologies such as AI to level the playing field. Women endure complex and nuanced health conditions and they deserve a solution that directly addresses them," Ovum co-founder Dr Ariella Heffernan-Mark said.
Antler partner James McClure said: "Dr. Ariella Heffernan-Mark's vision to empower women with greater control over their health data is both inspiring and essential. Her unwavering commitment to improving women's health outcomes is matched by her relentless execution".
The source: Ovum Press Release
